Expanded analysis for patients with acute cholecystitis indicates outcomes vary based on COVID-19 status and treatment modality.
Emily A GrimsleyJohnathan V TorikashviliHaroon M JanjuaRicardo PietrobonTyler ZanderMelissa A KendallPaul C KuoMeagan D Readnull nullPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2024)
Acute cholecystitis outcomes are affected by phase of COVID-19 infection and treatment modality. Cholecystectomy does not lead to worse outcomes for COVID-active and COVID-recovered patients than nonoperative treatments; thus, these patients can be considered for cholecystectomy if their physiology is not prohibitive.
Keyphrases
- coronavirus disease
- end stage renal disease
- sars cov
- ejection fraction
- chronic kidney disease
- newly diagnosed
- metabolic syndrome
- intensive care unit
- adipose tissue
- skeletal muscle
- insulin resistance
- respiratory failure
- combination therapy
- acute respiratory distress syndrome
- weight loss
- hepatitis b virus
- glycemic control